Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Healthcare

Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows

October 17, 2019 The Wall Street Analyzer Comments Off on Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows

New York City, Oct. 15, 2019 (GLOBE NEWSWIRE) — Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows New York City, New York – News yesterday from Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with […]

No Picture
Biotech

Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

October 1, 2019 The Wall Street Analyzer Comments Off on Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

Generex Biotechnology Corporation is an integrated healthcare holding company with end‐to‐end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. […]